Lissa Hooi

1.4k total citations
27 papers, 850 citations indexed

About

Lissa Hooi is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Lissa Hooi has authored 27 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Infectious Diseases. Recurrent topics in Lissa Hooi's work include Protein Degradation and Inhibitors (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Tuberculosis Research and Epidemiology (3 papers). Lissa Hooi is often cited by papers focused on Protein Degradation and Inhibitors (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Tuberculosis Research and Epidemiology (3 papers). Lissa Hooi collaborates with scholars based in Singapore, United States and China. Lissa Hooi's co-authors include Edward Kai‐Hua Chow, Tan Boon Toh, Jhin Jieh Lim, Masturah Bte Mohd Abdul Rashid, Wee Han Ang, Zhi Yang, Dean Ho, Bertrand Czarny, Maria V. Babak and Giorgia Pastorin and has published in prestigious journals such as Angewandte Chemie International Edition, ACS Nano and Biomaterials.

In The Last Decade

Lissa Hooi

27 papers receiving 833 citations

Peers

Lissa Hooi
Jia You China
Kentaro Matsumoto Japan
Benchen Rao China
Xing‐Chun Peng China
Victor Moyo United States
Xiyu Liu China
Huiyao Huang China
Shuliang Guo China
Connie Kang New Zealand
Jia You China
Lissa Hooi
Citations per year, relative to Lissa Hooi Lissa Hooi (= 1×) peers Jia You

Countries citing papers authored by Lissa Hooi

Since Specialization
Citations

This map shows the geographic impact of Lissa Hooi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lissa Hooi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lissa Hooi more than expected).

Fields of papers citing papers by Lissa Hooi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lissa Hooi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lissa Hooi. The network helps show where Lissa Hooi may publish in the future.

Co-authorship network of co-authors of Lissa Hooi

This figure shows the co-authorship network connecting the top 25 collaborators of Lissa Hooi. A scholar is included among the top collaborators of Lissa Hooi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lissa Hooi. Lissa Hooi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hooi, Lissa, Peter Wang, S. J. Chua, et al.. (2025). Flash optimization of drug combinations for Acinetobacter baumannii with IDentif.AI-AMR. PubMed. 3(1). 12–12. 1 indexed citations
2.
3.
Hooi, Lissa, Bettina Lieske, Alfred Wei Chieh Kow, et al.. (2024). A functional personalised oncology approach against metastatic colorectal cancer in matched patient derived organoids. npj Precision Oncology. 8(1). 52–52. 8 indexed citations
4.
Hooi, Lissa, Jhin Jieh Lim, Deepa Rajagopalan, et al.. (2023). Histone‐lysine N‐methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc‐driven liver cancer. Molecular Oncology. 17(11). 2275–2294. 12 indexed citations
5.
Hooi, Lissa, Touati Benoukraf, Pierce K. H. Chow, et al.. (2022). Hepatocellular carcinoma organoid co-cultures mimic angiocrine crosstalk to generate inflammatory tumor microenvironment. Biomaterials. 284. 121527–121527. 62 indexed citations
6.
Mukherjee, Devika, Peter Wang, Lissa Hooi, et al.. (2022). Addressing antimicrobial resistance with the IDentif.AI platform: Rapidly optimizing clinically actionable combination therapy regimens against nontuberculous mycobacteria. Theranostics. 12(16). 6848–6864. 11 indexed citations
7.
Lim, Jhin Jieh, Lissa Hooi, Yock Young Dan, et al.. (2022). Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors. Journal of Experimental & Clinical Cancer Research. 41(1). 249–249. 23 indexed citations
8.
Toh, Tan Boon, Lissa Hooi, Yock Young Dan, et al.. (2022). Splice‐switch oligonucleotide‐based combinatorial platform prioritizes synthetic lethal targets CHK1 and BRD4 against MYC ‐driven hepatocellular carcinoma. Bioengineering & Translational Medicine. 8(1). e10363–e10363. 9 indexed citations
9.
Blasiak, Agata, Jhin Jieh Lim, Theodore Kee, et al.. (2020). IDentif . AI : Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐Cov‐2) with digital drug development. Bioengineering & Translational Medicine. 6(1). e10196–e10196. 30 indexed citations
10.
Abdulla, Aynur, Qian Feng, Theodore Kee, et al.. (2020). Project IDentif.AI: Harnessing Artificial Intelligence to Rapidly Optimize Combination Therapy Development for Infectious Disease Intervention. Advanced Therapeutics. 3(7). 2000034–2000034. 43 indexed citations
11.
Babak, Maria V., Zhi Yang, Bertrand Czarny, et al.. (2019). Dual‐Targeting Dual‐Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity. Angewandte Chemie International Edition. 58(24). 8109–8114. 95 indexed citations
12.
Babak, Maria V., Zhi Yang, Bertrand Czarny, et al.. (2019). Dual‐Targeting Dual‐Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity. Angewandte Chemie. 131(24). 8193–8198. 27 indexed citations
13.
Toh, Tan Boon, Jhin Jieh Lim, Lissa Hooi, Masturah Bte Mohd Abdul Rashid, & Edward Kai‐Hua Chow. (2019). Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma. Journal of Hepatology. 72(1). 104–118. 97 indexed citations
14.
Rashid, Masturah Bte Mohd Abdul, Tan Boon Toh, Lissa Hooi, et al.. (2018). Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP). Science Translational Medicine. 10(453). 84 indexed citations
15.
Fong, Eliza Li Shan, Tan Boon Toh, Quy Xiao Xuan Lin, et al.. (2018). Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer. Biomaterials. 159. 229–240. 55 indexed citations
16.
Fong, Eliza Li Shan, Tan Boon Toh, Quy Xiao Xuan Lin, et al.. (2018). Datasets describing the growth and molecular features of hepatocellular carcinoma patient-derived xenograft cells grown in a three-dimensional macroporous hydrogel. Data in Brief. 18. 594–606. 4 indexed citations
17.
Gu, Mengjie, Xin Wang, Tan Boon Toh, et al.. (2018). Nanodiamond‐Based Platform for Intracellular‐Specific Delivery of Therapeutic Peptides against Hepatocellular Carcinoma. Advanced Therapeutics. 1(8). 15 indexed citations
18.
Hooi, Lissa, et al.. (2001). A study on community acquired pneumonia in adults requiring hospital admission in Penang.. PubMed. 56(3). 275–84. 18 indexed citations
19.
Hooi, Lissa, et al.. (1995). A hospital based audit of tuberculosis deaths.. PubMed. 50(4). 306–13. 9 indexed citations
20.
Hooi, Lissa. (1994). Case-finding for pulmonary tuberculosis in Penang.. PubMed. 49(3). 223–30. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jia You Breakdown of academic impact, for papers by Kentaro Matsumoto Breakdown of academic impact, for papers by Benchen Rao Breakdown of academic impact, for papers by Xing‐Chun Peng Breakdown of academic impact, for papers by Victor Moyo Breakdown of academic impact, for papers by Xiyu Liu Breakdown of academic impact, for papers by Huiyao Huang Breakdown of academic impact, for papers by Shuliang Guo Breakdown of academic impact, for papers by Connie Kang
Rankless by CCL
2026